UPDATED Dec 23, 2025
Discover large cap German Pharmaceuticals & Biotech companies that are on the DAX. These Pharmaceuticals & Biotech Companies are organised by Market Cap.
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
MRK | €120.55 | -0.5% | -12.5% | €52.4b | €143.56 | PE17.7x | E6.8% | 1.8% | ||
BAYN | €35.94 | 2.5% | 90.3% | €35.2b | €34.18 | PB1.2x | E44.5% | 0.3% | ||
1SXP | €14.90 | 0% | -39.8% | €2.2b | €22.97 | PE15.3x | E12.4% | 1.2% | ||
DMP | €38.50 | 4.1% | 1.9% | €2.1b | €42.00 | PE17.9x | E11.5% | 2.3% | ||
7ZT | €0.47 | -1.7% | n/a | €971.3m | n/a | PS4490.7x | n/a | n/a | ||
EVT | €5.39 | 3.4% | -35.9% | €955.4m | €8.46 | PS1.3x | E73.7% | n/a | ||
GXI | €26.90 | -0.6% | -61.6% | €929.1m | €33.81 | PE39.8x | E41.8% | 0.1% | ||
28L | €0.0002 | 0% | 0% | €560.2m | n/a | PS1.3x | n/a | n/a | ||
FYB | €24.85 | 6.7% | -52.7% | €439.0m | €43.71 | PS9.1x | E113.3% | n/a | ||
LQ0 | €0.74 | -2.6% | 127.0% | €161.8m | n/a | PS42.7x | n/a | n/a | ||
NV5 | €0.037 | -0.5% | -22.5% | €133.4m | n/a | PS10.8x | n/a | n/a | ||
HPHA | €2.40 | -10.1% | 10.1% | €112.3m | €6.75 | PS37x | E7.4% | n/a | ||
93M1 | €22.40 | -6.7% | 0.9% | €95.0m | €37.00 | PB0.5x | E130.1% | 5.4% | ||
7V0 | €7.75 | 18.3% | n/a | €93.0m | n/a | PE5x | n/a | 7.3% | ||
2INV | €11.50 | -1.7% | -1.7% | €63.4m | n/a | PE2.4x | n/a | n/a | ||
8V8 | €0.041 | -13.8% | 73.1% | €49.7m | n/a | PS1.5x | n/a | n/a | ||
HIGH | €3.39 | 10.1% | -32.9% | €42.3m | €8.25 | PS21.6x | E89.7% | n/a | ||
T9G | €0.57 | 0% | -12.3% | €29.4m | €4.20 | n/a | n/a | n/a | ||
FA0 | €0.017 | -10.8% | 17.9% | €29.0m | n/a | PS26.8x | n/a | n/a | ||
20B | €0.30 | 7.1% | 175.2% | €26.1m | n/a | PS412.6x | n/a | n/a | ||
SBX | €3.57 | 130.3% | -33.5% | €24.3m | €6.05 | n/a | E72.4% | n/a | ||
B8FK | €2.38 | -10.9% | 3.5% | €14.5m | n/a | PB0.7x | n/a | n/a | ||
HF00 | €0.13 | -8.8% | -77.1% | €12.5m | n/a | PB0.3x | n/a | n/a | ||
PJ2 | €3.80 | 0% | -0.7% | €11.8m | n/a | PS43.7x | S-149.8% | n/a |